| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8B | $10.4B | $10.5B | $8.8B | $8.2B | $2.5B | $2.2B | $2.2B |
| Cost of Revenue | $8.7B | $8.5B | $8.7B | $7.4B | $6.7B | $6.2B | $7.0B | $7.0B |
| Gross Profit | $2.1B | $1.9B | $1.8B | $1.4B | $1.5B | $0.5B | $0.4B | $0.4B |
| R&D Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | — | — | — |
| SG&A Expense | $0.6B | $0.5B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B |
| Operating Income | $1.1B | $1.0B | $0.7B | $0.7B | $0.7B | $0.4B | $0.7B | $0.7B |
| Net Income | $0.7B | $0.6B | $0.5B | $0.4B | $0.4B | $0.2B | $0.5B | $-0.1B |
| EPS (Basic) | $9.59 | $8.06 | $5.74 | $4.86 | $4.97 | $2.16 | $1.78 | $-1.07 |
| EPS (Diluted) | $9.55 | $8.04 | $5.72 | $4.85 | $4.96 | $2.15 | $1.78 | $-1.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.6B | $7.8B | $8.3B | $7.7B | $7.5B | $8.2B | $6.8B | $6.7B |
| Current Assets | $4.1B | $3.5B | $4.0B | $3.7B | $3.7B | $4.3B | $3.0B | $3.3B |
| Cash & Equivalents | $0.6B | $0.3B | $0.5B | $0.6B | $1.0B | $1.2B | $0.4B | $0.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.9B | $3.6B | $4.0B | $3.6B | $2.8B | $3.1B | $2.4B | $2.9B |
| Stockholders' Equity | $2.6B | $2.3B | $2.6B | $2.6B | $2.6B | $2.4B | $2.1B | $1.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.1B | $1.0B | $0.7B | $0.8B | $0.8B | $0.6B | $0.6B |
| Investing Cash Flow | $-0.4B | $-0.6B | $-0.6B | $-0.5B | $-0.5B | $-0.3B | $-0.5B | $-0.6B |
| Capital Expenditures | $0.4B | $0.6B | $0.6B | $0.6B | $0.5B | $0.3B | $0.5B | $0.6B |
| Financing Cash Flow | $-0.4B | $-0.7B | $-0.5B | $-0.5B | $-0.5B | $0.2B | $-0.3B | $-0.2B |